About Olympus Corp.
Olympus Corporation is engaged in the manufacture and sale of precision machineries and instruments. The Company's segments include Medical Business, Scientific Solutions Business, Imaging Business and Others. The Company's Medical Business manufactures and sells medical endoscopes, surgical endoscopes, endotherapy devices and other products. Its Scientific Solutions Business manufactures and sells biological microscopes, industrial microscopes, industrial endoscopes, non-destructive testing equipment and other products. Its Imaging Business manufactures and sells digital cameras, voice recorders and other products. Its Others Business manufactures and sells biomedical materials, conducts system development and other business activities. Its technologies include optical technologies, electronic imaging technologies, precision technologies and biological based technologies. It has a service network consisting of over 200 sites on approximately six continents.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: N/A
- Sub-Industry: N/A
- Exchange: OTCMKTS
- Symbol: OCPNY
- CUSIP:
Key Metrics:
- Previous Close: $34.91
- 50 Day Moving Average: $33.62
- 200 Day Moving Average: $36.97
- 52-Week Range: $30.91 - $42.02
- Trailing P/E Ratio: 22.32
- Foreward P/E Ratio: 35.26
- P/E Growth: 0.00
- Market Cap: $11.95B
- Outstanding Shares: 342,234,000
- Beta: 0.16
Profitability:- Net Margins: 6.91%
- Return on Equity: 19.45%
- Return on Assets: 7.34%
Debt:- Debt-to-Equity Ratio: 0.74%
- Current Ratio: 1.94%
- Quick Ratio: 1.50%
Additional Links:
Companies Related to Olympus Corp.:
Consensus Ratings for Olympus Corp. (OTCMKTS:OCPNY) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for Olympus Corp. (OTCMKTS:OCPNY)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Olympus Corp. (OTCMKTS:OCPNY)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 2/7/2014 | Q4 | | $0.42 | | | View | N/A |  |
(Data available from 1/1/2011 forward)
Earnings Estimates for Olympus Corp. (OTCMKTS:OCPNY)Current Year EPS Consensus Estimate: $1.13 EPS
Next Year EPS Consensus Estimate: $0.99 EPS
Dividend History for Olympus Corp. (OTCMKTS:OCPNY)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Olympus Corp. (OTCMKTS:OCPNY)
No insider trades for this company have been tracked by MarketBeat.com
Latest Headlines for Olympus Corp. (OTCMKTS:OCPNY)| Date | Headline |
|---|
 | ETF’s with exposure to Olympus Corp. : September 15, 2016 (OTCMKTS:OCPNY)
www.capitalcube.com - September 15 at 6:36 PM |
 | Congressman calls on Japanese prosecutors to probe Olympus over scope infections (OTCMKTS:OCPNY)
www.latimes.com - September 1 at 6:52 PM |
| ETF’s with exposure to Olympus Corp. : September 1, 2016 (OTCMKTS:OCPNY)
www.capitalcube.com - September 1 at 6:31 PM |
 | Correction: Hospital Superbug Outbreak story (OTCMKTS:OCPNY)
sg.finance.yahoo.com - August 27 at 10:51 AM |
| ETF’s with exposure to Olympus Corp. : August 12, 2016 (OTCMKTS:OCPNY)
www.capitalcube.com - August 12 at 6:44 PM |
| Olympus Corp. :OCPNY-US: Earnings Analysis: Q1, 2017 By the Numbers : August 8, 2016 (OTCMKTS:OCPNY)
www.capitalcube.com - August 8 at 6:51 PM |
| Olympus Eyes M&A in Ongoing Recovery (OTCMKTS:OCPNY)
finance.yahoo.com - July 20 at 9:30 PM |
| The Zacks Analyst Blog Highlights: Honda Motor, Toyota Motor, Canon and Olympus (OTCMKTS:OCPNY)
finance.yahoo.com - July 14 at 9:30 AM |
| Olympus Corporation of the Americas Enters Into US And Canada Distribution Agreement With Arc Medical Design Ltd, A Subsidiary Of Norgine For ENDOCUFF VISION® (OTCMKTS:OCPNY)
finance.yahoo.com - May 6 at 8:00 AM |
| Olympus Corp. :OCPNY-US: Earnings Analysis: Q4, 2016 By the Numbers (OTCMKTS:OCPNY)
www.capitalcube.com - May 4 at 10:38 AM |
| Report: More infections from dirty scopes than estimated (OTCMKTS:OCPNY)
sg.finance.yahoo.com - April 15 at 6:00 PM |
 | [video]Olympus Teams Up With Sony for Surgical Big Screen TV (OTCMKTS:OCPNY)
www.thestreet.com - April 9 at 10:26 PM |
| Olympus sought price hike for UCLA amid superbug outbreak (OTCMKTS:OCPNY)
www.latimes.com - March 25 at 6:04 AM |
 | Whistleblower Delivers A Triple Whammy To Olympus; More Companies Might Get Hit (OTCMKTS:OCPNY)
www.forbes.com - March 4 at 5:45 PM |
 | Whistleblower wins $51 million in kickback and bribery case (OTCMKTS:OCPNY)
money.cnn.com - March 2 at 2:40 PM |
| Olympus to pay at least $635 million to settle kickback and bribery cases (OTCMKTS:OCPNY)
www.latimes.com - March 1 at 2:20 PM |
| Olympus to pay at least $646 million to end US probes (OTCMKTS:OCPNY)
sg.finance.yahoo.com - March 1 at 1:58 PM |
 | Olympus Will Pay $646 Million to End Kickback, Bribe Probes (OTCMKTS:OCPNY)
www.bloomberg.com - March 1 at 10:27 AM |
| Olympus settles with Japan whistleblower after 8-year battle (OTCMKTS:OCPNY)
finance.yahoo.com - February 18 at 2:34 AM |
| Olympus Corp. Earnings Analysis: Q3, 2016 By the Numbers (OTCMKTS:OCPNY)
www.capitalcube.com - February 10 at 11:39 AM |
 | FDA Approves Fixes for Olympus Scope Linked to Infections (OTCMKTS:OCPNY)
www.wsj.com - January 17 at 7:57 PM |
| Olympus to recall and redesign medical scope linked to superbug outbreaks (OTCMKTS:OCPNY)
www.latimes.com - January 15 at 1:04 PM |
| Ex-Olympus CEO Woodford Sues Company for Breach of Contract (OTCMKTS:OCPNY)
www.bloomberg.com - January 15 at 12:59 PM |
 | Congressman wants SEC probe into Olympus over superbug outbreak (OTCMKTS:OCPNY)
www.bizjournals.com - December 23 at 4:00 PM |
| Medtronic-Samsung to Advance Neuromodulation Therapy (OTCMKTS:OCPNY)
finance.yahoo.com - December 14 at 2:20 PM |
| Becton, Dickinson Unveils BD FACSCelesta Flow Cytometer (OTCMKTS:OCPNY)
finance.yahoo.com - December 14 at 1:20 PM |
| St. Jude Medical Unveils Positive Data from SUNBURST Study (OTCMKTS:OCPNY)
finance.yahoo.com - December 14 at 1:10 PM |
| FDA OKs Medtronic Activa DBS System for Full-Body MRI Scan (OTCMKTS:OCPNY)
finance.yahoo.com - December 11 at 2:10 PM |
| Edwards Lifesciences Reveals 2016 and Long-Term Outlook (OTCMKTS:OCPNY)
finance.yahoo.com - December 10 at 2:15 PM |
| athenahealth Unveils 2016 Outlook; 2015 Projections Intact (OTCMKTS:OCPNY)
finance.yahoo.com - December 10 at 1:00 PM |
| Becton, Dickinson IV Solution to Aid Medication Management (OTCMKTS:OCPNY)
finance.yahoo.com - December 9 at 12:50 PM |
| Allscripts (MDRX) Rides High on Partnerships, Customer Wins (OTCMKTS:OCPNY)
finance.yahoo.com - December 8 at 9:50 AM |
| Cerner's HealtheIntent on a Roll: Wins a String of Contracts (OTCMKTS:OCPNY)
finance.yahoo.com - December 7 at 4:45 PM |
| St. Jude Receives CE Mark for MRI on Quadra Assura CRT-D (OTCMKTS:OCPNY)
finance.yahoo.com - December 7 at 4:05 PM |
| Cooper Companies Q4 Earnings, Revenues Lag; Stock Down (OTCMKTS:OCPNY)
finance.yahoo.com - December 4 at 10:10 AM |
Olympus Corp. (OTCMKTS:OCPNY) Chart for Wednesday, September, 28, 2016
